Full Press Release Details
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
MIRM Neutral Sentiment
Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Key Takeaway: Mirum Pharmaceuticals has released its financial results for the second quarter of 2026, along with a business update. The report highlights key financial metrics and strategic initiatives. Further details on the company's performance and future plans were also shared.
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+74%
120-day peak, hindsight
Typical move
3.1%
average across 9 past catalysts
Cash runway
~3 mo
High dilution risk
Lead asset
Blinded CDCA
Phase 3 · CTX